Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

Catherine G. Ambrose, Medical School (MS), Effects of NSAIDS on Osteointegration, Zimmer, $56,701.

Raul Caetano, School of Public Health (SPH), Collaborative Alcohol Research Development and Planning, University of Hawaii, $30,536.

Giuseppe N. Colasurdo, MS, The Role of Nitric Oxide in Respiratory Syncytial Virus Infection in the Mouse Model of Cystic Fibrosis, Baylor College of Medicine, $8,250.

Kevin J. Coupe, MS, Development of a Trauma Database for a Level I Trauma Center, Zimmer, $47,791.

Pramod K. Dash, MS and Graduate School of Biomedical Sciences (GSBS), Proteomics of Brain-Trauma Associated Elevated Intracranial Pressure, The Institute for Rehabilitation and Research, $119,273.

Jay H. Glasser, SPH, China - USA Medicine and Public Health Initiative, China Medical Board of New York Inc., $98,000.

James C. Grotta, MS, CHANT: A Double Blind, Randomized Placebo-Controlled, Parallel Group, Multicenter, Phase IIB Study to Assess the Safety and Tolerability of 72 Hours Intravenous Infusion on NXY-059 in Adult Patients with Intracerebral Hemorrhage SANXY-0012, Astrazeneca, $157,500.

J.William Lindsey, MS and GSBS, Open-Label Extension Study to Evaluate the Safety, Tolerability, and Activity of Oral Pampridine-SR in Subjects with Multiple Sclerosis, Acorda Therapeutics Inc., $17,841.

Katherine A. Loveland, MS and GSBS, Diffusion Tensor Imaging of Brain Matter Connectivity in Adolescents with Autism, Baylor College of Medicine, $12,449.

Marc D. Malkoff, MS, Investigation of the Natural History of West Nile Virus Infection in Patients with or at Risk for Progression to West Nile Virus Encephalitis and/or Myelitis, University of Alabama at Birmingham, $924,000; A Phase I/II Randomized, Placebo- Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (OMR-IGG-AM) Containing High Anti-West Nile Virus Antibody Titers in Patients with, or at High Risk for, Progression to West Nile Virus Encephalitis and/or Myelitis, University of Alabama at Birmingham, $1,400,000.

Marianne T. Marcus, School of Nursing, Stress Reduction in Therapeutic Community Treatment, National Institutes of Health (NIH), National Institute on Drug Abuse, $1,407,453. John Mohr, MS, A Retrospective Evaluation of the Relative Effect of Fluoroquinolones on the Induction of Glucose Abnormalities, Bristol-Myers Squibb Co., $41,225.

Kathy L. O’Keefe, Dental Branch (DB), Bond Strength of Resin Composite to Pre-Treated Enamel, Kuraray Co. Ltd, $96,000; and Bond Strength of All-In-One Adhesives to Enamel and Dentin, Kuraray Co. Ltd, $12,000.

Joe Ontiveros, DB, Bond Strength of Self Etching Adhesives, Discus Dental Inc., $6,400.

Luis Ostrosky-Zeichner, MS, Beta Glucan Measurement in Samples from BAMSG 2-01 Study “A Randomized, Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting,” Merck & Co. Inc., $152,690.

John M. Powers, DB and GSBS, Flexural Properties of Modified Resin Composite, Discus Dental Impressions Inc., $1,000; Bond Strength of Experimental Bonding Agent, 3M ESPE Dental Products, $4,800; Bond Strength of Bonding Agent 1P-SEA, Dentsply International, $1,600; Bond Strength of Estiseal F Bonded with IBond in Contaminated Environments, Heraeus Kulzer Inc., $2,500; Bond Strength of K 0127 Formulations to Enamel and Dentin, Dentsply International, $6,400; Color Stability of Ceremics, University of Michigan, $1,000; and Surface Roughness and Gloss of Venus with IPOL, Heraeus Kulzer Inc., $600.

S. Noor N. Rahman, MS, A Randomized, Controlled, Open-Label Study of the Safety and Efficacy of Ferriecit Vs Oral Iron in Iron Deficient Patients with Chronic Kidney Disease,Watson Laboratories Inc., $58,180.

David J. Robinson, MS, Improving Antibiotic Use in Acute Care Treatment, University of California at San Francisco, $14,800.

Gwendolyn C. Sherwood, SON, Public Health Preparedness/Response: Stipend for Graduate Nurses, Texas Department of Health, $20,000.

Jerry S.Wolinsky, MS and GSBS, MRI Analysis Center for A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Design Study to Evaluate the Efficacy and Safety of Teriflunomide (HMR1726D) in Reducing the Frequency of Relapses and Delaying the Accumulation of Physical Disability in Subjects with Multiple Sclerosis with Relapses, Aventis Pharmaceuticals Inc., $3,406,710.

Jiajie Zhang, School of Health Information Sciences, Cognition and Error Management for Critical Care, Columbia University, $119,454.

Renewal

Stephen L. Mills, MS and GSBS, Connectivity Patterns in Retinal Bipolar Cells, NIH, National Eye Institute, $717,701.

Ke-He Ruan, MS and GSBS, PGIS, TXAS & PGES: Structure/Function, NIH, National Heart, Lung and Blood Institute, $1,299,375.

Gwendolyn C. Sherwood, SON, Advanced Education Nursing Traineeship, Health Resources and Services Administration, $97,489.